As the 2025–2026 session of the United States Congress continues, lawmakers have introduced a wide range of cannabis-related bills and resolutions, with proposals addressing descheduling, veterans access, marijuana businesses, federally assisted housing, university research, hemp restrictions and cannabinoid product regulation. None has been enacted, but each remains active during the current congressional session.

Below is a breakdown of every cannabis-related bill currently active during the 2025–2026 session of the United States Congress.

Marijuana Opportunity Reinvestment and Expungement (MORE) Act (H.R. 5068)

The MORE Act would fully remove marijuana from the Controlled Substances Act, ending federal prohibition altogether. It would also establish automatic expungement for certain federal marijuana offenses, create a new federal excise tax on marijuana products and direct revenue toward community reinvestment and small business programs. The bill has 72 total sponsors.

Hemp Planting Predictability Act and Related Hemp Delay Bill (H.R. 7010 / H.R. 7024 / S. 3686)

The Hemp Planting Predictability Act and a related House hemp-delay bill would delay implementation of new federal hemp restrictions enacted through Public Law 119-37. Under current law, those changes are set to take effect after 365 days, but the measures would replace that timeline with three years, giving hemp farmers, manufacturers, retailers and regulators more time before the new rules take effect. H.R. 7024 and S. 3686 have a combined 36 total sponsors, while the related H.R. 7010 has five total sponsors.

No Deductions for Marijuana Businesses Act (H.R. 1447 / S. 471)

Rather than loosening federal tax restrictions, this bill would explicitly preserve Section 280E, which bars marijuana businesses from claiming standard business deductions, even after marijuana is rescheduled from Schedule I to Schedule III. Under current law, Section 280E applies only to substances classified as Schedule I or II. The House and Senate versions have a combined 15 total sponsors.

RESPECT Resolution (H. Res. 926)

The Realizing Equitable & Sustainable Participation in Emerging Cannabis Trades Resolution, or RESPECT Resolution, encourages state and local governments to adopt equity-focused marijuana policies. Rather than changing federal law directly, it promotes expanded business opportunities, access to capital, expungement, reinvestment and economic participation for communities disproportionately impacted by past marijuana enforcement. The resolution has 11 total sponsors.

STATES 2.0 Act (H.R. 2934)

The STATES 2.0 Act would prohibit federal enforcement actions against individuals and businesses operating in compliance with state or tribal marijuana laws. It would authorize interstate commerce between legal jurisdictions, remove marijuana businesses from the reach of Section 280E and establish a federal regulatory structure with relatively low tax rates. The bill has eight total sponsors.

Hemp Enforcement, Modernization, and Protection Act (H.R. 7212)

The Hemp Enforcement, Modernization, and Protection Act would amend the Federal Food, Drug, and Cosmetic Act to create a national regulatory framework for cannabinoid hemp products. The proposal would establish federal standards for labeling, testing, manufacturing, product listings, facility registration and recalls, while barring sales to anyone under 21. The bill has six total sponsors.

Marijuana in Federally Assisted Housing Parity Act of 2025 (H.R. 6807 / S. 3537)

The Marijuana in Federally Assisted Housing Parity Act would prohibit public housing authorities and other federally assisted housing providers from denying admission to, or evicting, individuals solely for using marijuana in compliance with state law. Under current federal policy, marijuana remains prohibited in federally subsidized housing regardless of state legalization, creating conflicts for tenants in legal states. The House and Senate versions have a combined three total sponsors.

Capital Lending and Investment for Marijuana Businesses (CLIMB) Act (H.R. 7987)

The Capital Lending and Investment for Marijuana Businesses Act, or CLIMB Act, would allow state-legal marijuana businesses to list on major national stock exchanges such as Nasdaq and the New York Stock Exchange. It would also protect businesses and individuals that provide services to state-legal marijuana companies, including banks, insurers, investors, accountants, attorneys, marketers, tech firms and real estate providers. The bill has four total sponsors.

Marijuana 1-to-3 Act (H.R. 4963)

The Marijuana 1-to-3 Act would move marijuana from Schedule I to Schedule III under the Controlled Substances Act. The proposal has become less central to the federal debate following recent federal action moving certain FDA-approved and state-licensed medical marijuana products to Schedule III, but it remains active in Congress. The bill has four total sponsors.

Cannabinoid Safety and Regulation Act (S. 3474)

The Cannabinoid Safety and Regulation Act would create a federal framework for regulating cannabis and cannabinoid products. The measure includes provisions related to FDA oversight, product standards, labeling, testing, underage-use prevention, public health grants and cannabis-impaired driving. The bill has three total sponsors.

Hemp Safety Enforcement Act (S. 4315)

The Hemp Safety Enforcement Act would allow states and tribes to maintain their own hemp laws despite the newer federal hemp restrictions enacted through Public Law 119-37. The bill would give states and tribes a pathway to preserve legal hemp and hemp-derived cannabinoid markets if they submit notice and meet certain requirements. The bill has three total sponsors.

American Hemp Protection Act of 2025 (H.R. 6209)

The American Hemp Protection Act would repeal Section 781 of Public Law 119-37, the provision that enacted new restrictions on hemp and hemp-derived products. Unlike the Hemp Planting Predictability Act, which would delay implementation, this bill would undo the hemp changes entirely. The bill has four total sponsors.

Evidence-Based Drug Policy Act of 2025 (H.R. 3082)

The Evidence-Based Drug Policy Act would repeal the requirement that the Office of National Drug Control Policy oppose marijuana legalization as a matter of law. By removing that mandate, the bill would allow federal drug policy positions to be guided by scientific research and public health data rather than statutory prohibition language. The bill has two total sponsors.

Small and Homestead Independent Producers Act of 2025 (H.R. 4595)

The Small and Homestead Independent Producers Act would allow small marijuana cultivators and small manufacturers of marijuana products to ship cannabis and cannabis products through the mail in states where such activity is lawful. The bill would apply to shipments made through the U.S. Postal Service or private and commercial interstate carriers, while requiring age verification and limiting delivery to individuals who are at least 21. The bill has two total sponsors.

Marijuana Impact on Medicaid Act of 2026 (S. 4345)

The Marijuana Impact on Medicaid Act would require the U.S. Department of Health and Human Services to collect data and report to Congress on Medicaid costs tied to hospital inpatient care, outpatient hospital care and emergency room visits related to marijuana use. The report would be due within one year of enactment and could include recommendations for legislative or administrative action. The bill has two total sponsors.

Higher Education Marijuana Research Act of 2026 (H.R. 8394)

The Higher Education Marijuana Research Act would streamline the process for colleges and universities to conduct marijuana research. The bill would allow certain institutions in legal states or tribal jurisdictions to obtain marijuana from state or tribal regulatory bodies or law enforcement for research purposes, while protecting students, researchers and institutions from losing federal funding or other federal benefits solely due to participation in approved research. The bill has two total sponsors.

Veterans Cannabis Use for Safe Healing Act (H.R. 966)

The Veterans Cannabis Use for Safe Healing Act would bar the Department of Veterans Affairs from denying benefits solely because a veteran participates in a state-legal medical marijuana program. It would also allow VA providers to discuss marijuana use with patients and include it in treatment planning. The bill has two total sponsors.

Veterans Equal Access Act (H.R. 1384)

The Veterans Equal Access Act would allow VA doctors to discuss medical marijuana with patients and complete state-required certification forms where medical marijuana is legal. The bill is narrower than the Veterans Cannabis Use for Safe Healing Act, but it addresses a long-standing barrier for veterans seeking access to medical marijuana through state programs. The bill has four total sponsors.

PREPARE Act (H.R. 2935 / S. 3576)

The Preparing Regulators Effectively for a Post-Prohibition Adult-Use Regulated Environment Act, or PREPARE Act, would direct federal agencies to begin planning for a potential post-prohibition marijuana framework. It calls for analysis of regulatory models, tax structures and public health considerations that would arise if marijuana were descheduled, without directly changing marijuana’s legal status. The House and Senate versions have a combined four total sponsors.

Hemp Economic Mobilization Plan Act of 2025 (S. 2112)

The Hemp Economic Mobilization Plan Act, or HEMP Act, would revise the federal definition of legal hemp by increasing the allowable delta-9 THC threshold from 0.3% to 1% on a dry-weight basis. It would also update testing and transport documentation requirements, giving hemp producers more flexibility and reducing the risk of crop failures caused by plants testing slightly above the current federal threshold. The bill has one sponsor.